Sp1 and AP2 transcription factors are required for the human fragile mental retardation promoter activity in SK-N-SH neuronal cells

Neuroscience Letters

Volumn 276, Issue 3, 1999, Pages 149-152

  Carrillo, Carmen ^a   Cisneros, Bulmaro ^a   Montañez, Cecilia ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Fragile mental retardation promoter; Promoter activity; Sp1, AP2

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DNA FRAGMENT; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1;

ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DELETION MUTANT; DNA FOOTPRINTING; FRAGILE X SYNDROME; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; MENTAL DEFICIENCY; NEUROBLASTOMA CELL; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA; DNA FOOTPRINTING; DNA-BINDING PROTEINS; FRAGILE X MENTAL RETARDATION PROTEIN; GENE DELETION; HUMANS; NERVE TISSUE PROTEINS; NEURONS; PLASMIDS; PROMOTER REGIONS (GENETICS); RNA-BINDING PROTEINS; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0032718839     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00798-3     Document Type: Article

References (21)

1. Ashley C.T., Wilkinson K.D., Reines D., Warren S.T. FMR1 protein: conserved RNP family domains and selective RNA binding. Science. 262:1993;563-566.
2. Bachner D., Steinbach P., Wohrle D., Just W., Vogel W., Hameister H., Manca A., Poustka A. Enhanced Fmr1 expression in testis. Nat. Genet. 4:1993;115-116.
3. Boshart M., Klüppel M., Schmidt A., Schütz G., Luckow B. Reporter constructs with low background activity utilizing the cat gene. Gene. 110:1992;129-130.
4. Chiurazzi P., Pomponi M.G., Willemsen R., Oostra B.A., Neri G. In vitro reactivation of the FMR1 gene involved in fragile X syndrome. Hum. Mol. Genet. 7:1998;109-113.
5. Devys D., Lutz Y., Rouyer N., Bellocq J.-P., Mandel J.-L. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of the fragile X premutation. Nat. Genet. 4:1993;335-340.
6. Drouin R., Angers M., Dallaire N., Rose T.M., Khandjian E.W., Rousseau F. Structural and functional characterization of the human FMR1 promoter reveals similarities with the hnRNP-A2 promoter region. Hum. Mol. Genet. 6:1997;2051-2060.
7. Eichler E.E., Richards S., Gibbs R.A., Nelson D.L. Fine structure of the human FMR1 gene. Hum. Mol. Genet. 2:1993;1147-1153.
8. Fu Y.-H., Kuhl D.P.A., Pizzuti A., Pieretti M., Sutcliffe J.S., Richards S., Verkerk A.J.M.H., Holden J.J.A., Fenwick R.G., Warren S.T., Oostra B.A., Nelson D.L., Caskey C.T. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 67:1991;1047-1058.
9. Hinds H.L., Ashley C.T., Sutcliffe J.S., Nelson D.L., Warren S.T., Housman D.E., Schalling M. Tissue specific expression of FMR1 provides evidence for a functional role in fragile X syndrome. Nat. Genet. 3:1993;36-43.
10. Hwu W.-L., Lee Y.-M., Lee S.-C., Wang T.-R. In vitro methylation inhibits FMR-1 promoter. Biochem. Biophys. Res. Commun. 193:1993;324-329.
11. Hwu W.-L., Wang T.R., Lee Y.M. FMR1 enhancer is regulated by cAMP through a cAMP-responsive element. DNA Cell. Biol. 16:1997;449-453.
12. Khandjian E.W., Fortin A., Thibodeau A., Tremblay S., Coté F., Devys D., Mandel J.-L., Rousseau F. A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and modulated in cell culture. Hum. Mol. Genet. 4:1995;783-789.
13. Mitchell P.J., Wang C., Tjian R. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell. 50:1987;847-861.
14. Oberlé I., Rousseau F., Heitz D., Kretz C., Devys D., Hanouer A., Boué J., Bertheas M.F., Mandel J.-L. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science. 252:1991;1097-1102.
15. Sandberg G., Schalling M. Effect of in vitro promoter methylation and CGG repeat expansion on FMR-1 expression. Nucl. Acids Res. 25:1997;2883-2887.
16. Schwemmle S., de Graaff E., Deissler H., Glässer D., Wöhrle D., Kennerknecht I., Just W., Oostra B.A., Dörfler W., Vogel W., Steinbach P. Characterization of FMR1 promoter elements by in vivo-footprinting analysis. Am. J. Hum. Genet. 60:1997;1354-1362.
17. Sutcliffe J.S., Nelson D.L., Zhang F., Pieretti M., Caskey C.T., Sxe D., Warren S.T. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1:1992;397-400.
18. Turner G., Webb T., Wake S., Robinson H. Prevalence of fragile X syndrome. Am. J. Med. Genet. 64:1996;196-197.
19. Verheij C., Bakker C.E., de Graaf E., Keulemans J., Willemsen R., Verkerk A.J., Galjaard H., Reuser A.J., Hoogeveen A.T., Oostra B.A. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature. 363:1993;722-724.
20. Verkerk A., Pieretti M., Sutcliffe J., Fu Y.-H., Kuhl D., Pizzuti A., Reiner O., Richards S., Victoria M., Zhang F., Eussen B., van Ommen G.-J.B., Blonden L., Riggins G., Chastain J., Kunst C., Galjaard H., Caskey C., Nelson D., Oostra B., Warren S. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 65:1991;905-914.
21. Willemsen R., Bontekoe C., Tamanini F., Galjaard H., Hoogeveen A., Oostra B.A. Association of FMRP with ribosomal precursor particles in the nucleolus. Biochem. Biophys. Res. Commun. 225:1996;27-33.